Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Minoxidil effectively treats female pattern hair loss.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Topical botanical lotion increases hair density and improves quality of life in women with hair loss.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Early identification of lupus through skin signs and blood tests is crucial in India.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.